Advertisement
News
Subscribe to MDT Magazine News

Dentsply 1Q profit rises 12 percent

April 28, 2011 7:45 am | by The Associated Press | Comments

Dentsply International Inc. said Thursday its first-quarter net income rose 12 percent on higher sales of dental products.But, the company set new, lower profit guidance for 2011 after considering supply chain disruptions in the Japanese market in the aftermath of the March 11 earthquake and...

imX Learning Labs to Provide Guidance, Foster Partnerships for the Future of Manufacturing

April 28, 2011 7:39 am | by Society of Manufacturing Engineers | Comments

LAS VEGAS — April 28, 2011 — Manufacturers from across the country will participate in a one-of-a-kind series of “Learning Labs” this fall as part of the Interactive Manufacturing Experience (imX). The event features an unprecedented industry summit to chart a new course for...

Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estima...

April 28, 2011 6:38 am | by Bio-Medicine.Org | Comments

LAWRENCE, Mass., April 28, 2011 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today commented on study results presented by the Chronic Disease Research Group (CDRG) showing daily home hemodialysis with the NxStage System One is...

TOPICS:
Advertisement

Zentrip Offers a 'Sea Change' in Stopping the Distress from Motion Sickness

April 28, 2011 6:37 am | by Bio-Medicine.Org | Comments

TORRANCE, Calif., April 28, 2011 /- There's a sea change sweeping across the country on how people treat themselves for motion sickness. No longer do they need to carry bottles of liquid and slow-acting pills on their travels, worrying about getting seasick or motion sickness in a car,...

TOPICS:

Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 13th International Myeloma Workshop

April 28, 2011 6:37 am | by Bio-Medicine.Org | Comments

SOUTH SAN FRANCISCO, Calif., April 28, 2011 /- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the 13th International Myeloma Workshop (IMW), May 3-6, 2011, in...

TOPICS:

SUPERA VERITAS® Receives Regulatory Approval in Australia

April 28, 2011 6:35 am | by Bio-Medicine.Org | Comments

WEBSTER, Texas, April 28, 2011 /- IDEV Technologies, Inc. (IDEV) today announced the firm has received approval from the Therapeutic Goods Administration (TGA), Australia's regulatory agency for medical drugs and devices, for the SUPERA VERITAS® stent system for use in biliary and...

TOPICS:

CryoLife Posts Record Quarterly Revenues of $30.2 Million

April 28, 2011 6:35 am | by Bio-Medicine.Org | Comments

ATLANTA, April 28, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today its results for the first quarter of 2011.  Revenues for the first quarter increased 2 percent to a quarter record of $30.2...

TOPICS:

Cardica to Announce Fiscal 2011 Third Quarter Financial Results on Tuesday, May 10, 2011

April 28, 2011 6:35 am | by Bio-Medicine.Org | Comments

REDWOOD CITY, Calif., April 28, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that it will release financial results for its fiscal third quarter ended March 31, 2011, on Tuesday, May 10, 2011, after the markets close. Cardica's management will host a conference call at 4:30 p.m....

TOPICS:
Advertisement

MAQUET Cardiovascular Receives 510(k) Clearance to Market the CARDIOHELP System in U.S.

April 28, 2011 6:35 am | by Bio-Medicine.Org | Comments

WAYNE, N.J., April 28, 2011 /- MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its CARDIOHELP System in the United States as a cardiac and/or respiratory assist device for up to six hours.  The...

TOPICS:

Onda Reaches Distribution Agreement with S & V Korea to Expand Presence in South Korea

April 28, 2011 6:34 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., April 28, 2011 /- Onda Corporation, the leading global provider of ultrasound measurement instrumentation, announced an agreement with S&V Korea for distribution of its products to the government and academic sector in South Korea. S&V Korea is a leading...

TOPICS:

Public Workshop - Study Methodologies for Diagnostics in the Postmarket Setting, May 12, 2011

April 28, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

The purpose of the workshop is to provide a forum for discussion among FDA, governmental agencies, academia, physicians and various stakeholders with expertise in epidemiology, statistics, diagnostics and biomedical research to advance the methodologies f

TOPICS:

BIOLASE to Present at MDB Capital's Bright Lights Conference in New York City

April 28, 2011 5:45 am | by The Associated Press | Comments

BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that management is scheduled to make an investor presentation at MDB Capital's 2nd Annual Bright Lights Conference on Tuesday, May 10, at 9:30 am Eastern Time. The...

PositiveID Corporation's iglucose Mobile Health Solution for Diabetes Management to be Featured at American Telemedicine Association Annual International Meeting & Exhibition ...

April 28, 2011 5:32 am | by PositiveID | Comments

PositiveID Corporation's iglucose Mobile Health Solution for Diabetes Management to be Featured at American Telemedicine Association Annual International Meeting & Exhibition 2011

TOPICS:

Medco Health Solutions 1Q profit rises 4 percent

April 28, 2011 3:45 am | by The Associated Press | Comments

Pharmacy benefits manager Medco Health Solutions Inc. said Thursday its profit rose 4 percent in the first quarter on an increase in the volume of mail-order generic drug prescriptions and retail prescriptions.The Franklin Lakes, N.J., company said its profit rose to $333.1 million, or 80 cents...

STAAR Surgical's nanoFLEX™ Collamer® IOL Receives CE Mark Approval

April 28, 2011 3:36 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., April 28, 2011 /- STAAR Surgical Company (NASDAQ: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX™ Collamer® Single Piece IOL which can be injected through a...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading